Update of Pediatric Heart Failure

Kae Watanabe; Renata Shih

doi:10.1016/j.pcl.2020.06.004

Update of Pediatric Heart Failure

Kae Watanabe^*, Renata Shih

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Abstract

Pediatric heart failure (PHF) affects 0.87 to 7.4 per 100,000 children. It has a 5-year mortality or heart transplant rate of 40%. Diagnosis often is delayed because initial symptoms are similar to common pediatric illnesses. Disease progression is tracked by symptoms, echocardiogram, and biomarkers. Treatment is extrapolated from mostly adult heart failure (HF) literature. Recent studies demonstrate differences between pediatric and adult HF pathophysiology. Increased collaboration among PHF programs is advancing the management of PHF. Unfortunately, there are patients who ultimately require heart transplantation, with increasing numbers supported by a ventricular assist device as a bridge to transplantation.

Original language	English (US)
Pages (from-to)	889-901
Number of pages	13
Journal	Pediatric Clinics of North America
Volume	67
Issue number	5
DOIs	https://doi.org/10.1016/j.pcl.2020.06.004
State	Published - Oct 2020

Keywords

Cardiomyopathy in infants and children
Heart failure in congenital heart disease
Heart failure in pediatric acquired heart disease
Pediatric heart failure

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1016/j.pcl.2020.06.004

Cite this

@article{3c0c3e24c3c04d52a8922af3c4e35877,

title = "Update of Pediatric Heart Failure",

abstract = "Pediatric heart failure (PHF) affects 0.87 to 7.4 per 100,000 children. It has a 5-year mortality or heart transplant rate of 40%. Diagnosis often is delayed because initial symptoms are similar to common pediatric illnesses. Disease progression is tracked by symptoms, echocardiogram, and biomarkers. Treatment is extrapolated from mostly adult heart failure (HF) literature. Recent studies demonstrate differences between pediatric and adult HF pathophysiology. Increased collaboration among PHF programs is advancing the management of PHF. Unfortunately, there are patients who ultimately require heart transplantation, with increasing numbers supported by a ventricular assist device as a bridge to transplantation.",

keywords = "Cardiomyopathy in infants and children, Heart failure in congenital heart disease, Heart failure in pediatric acquired heart disease, Pediatric heart failure",

author = "Kae Watanabe and Renata Shih",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = oct,

doi = "10.1016/j.pcl.2020.06.004",

language = "English (US)",

volume = "67",

pages = "889--901",

journal = "Pediatric Clinics of North America",

issn = "0031-3955",

publisher = "W.B. Saunders",

number = "5",

}

TY - JOUR

T1 - Update of Pediatric Heart Failure

AU - Watanabe, Kae

AU - Shih, Renata

PY - 2020/10

Y1 - 2020/10

N2 - Pediatric heart failure (PHF) affects 0.87 to 7.4 per 100,000 children. It has a 5-year mortality or heart transplant rate of 40%. Diagnosis often is delayed because initial symptoms are similar to common pediatric illnesses. Disease progression is tracked by symptoms, echocardiogram, and biomarkers. Treatment is extrapolated from mostly adult heart failure (HF) literature. Recent studies demonstrate differences between pediatric and adult HF pathophysiology. Increased collaboration among PHF programs is advancing the management of PHF. Unfortunately, there are patients who ultimately require heart transplantation, with increasing numbers supported by a ventricular assist device as a bridge to transplantation.

AB - Pediatric heart failure (PHF) affects 0.87 to 7.4 per 100,000 children. It has a 5-year mortality or heart transplant rate of 40%. Diagnosis often is delayed because initial symptoms are similar to common pediatric illnesses. Disease progression is tracked by symptoms, echocardiogram, and biomarkers. Treatment is extrapolated from mostly adult heart failure (HF) literature. Recent studies demonstrate differences between pediatric and adult HF pathophysiology. Increased collaboration among PHF programs is advancing the management of PHF. Unfortunately, there are patients who ultimately require heart transplantation, with increasing numbers supported by a ventricular assist device as a bridge to transplantation.

KW - Cardiomyopathy in infants and children

KW - Heart failure in congenital heart disease

KW - Heart failure in pediatric acquired heart disease

KW - Pediatric heart failure

UR - http://www.scopus.com/inward/record.url?scp=85089286825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089286825&partnerID=8YFLogxK

U2 - 10.1016/j.pcl.2020.06.004

DO - 10.1016/j.pcl.2020.06.004

M3 - Review article

C2 - 32888688

AN - SCOPUS:85089286825

SN - 0031-3955

VL - 67

SP - 889

EP - 901

JO - Pediatric Clinics of North America

JF - Pediatric Clinics of North America

IS - 5

ER -

Update of Pediatric Heart Failure

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this